The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure

International Journal of Cardiology

Volumn 205, Issue , 2016, Pages 6-12

  Ebner, Nicole ^a,b   Jankowska, Ewa A ^c   Ponikowski, Piotr ^c   Lainscak, Mitja ^d,e   Elsner, Sebastian ^b   Sliziuk, Veronika ^b   Steinbeck, Lisa ^b   Kube, Jennifer ^b   Bekfani, Tarek ^b   Scherbakov, Nadja ^b   Valentova, Miroslava ^a,f   Sandek, Anja ^a,b   Doehner, Wolfram ^b   Springer, Jochen ^a   Anker, Stefan D ^a,b   Von Haehling, Stephan ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d General Hospital Celje   (Slovenia)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

^f Faculty of Natural Sciences   (Slovakia)

Author keywords

Anaemia; Exercise capacity; Heart failure; Iron deficiency

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FERRITIN; HEMOGLOBIN; TRANSFERRIN;

6 MINUTE WALK TEST; ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEATH; ERGOMETRY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPIROMETRY; SURVIVAL RATE; TRANSFERRIN SATURATION; ANEMIA, IRON-DEFICIENCY; BLOOD; CHRONIC DISEASE; COHORT ANALYSIS; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84955449424     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.11.178     Document Type: Article

References (32)

1. N.P. Arora, and J.K. Ghali Iron deficiency anemia in heart failure Heart Fail. Rev. 2012 10.1007/s10741-012-9342-y
2. M. Komajda, S.D. Anker, A. Charlesworth, D. Okonko, M. Metra, A. Di Lenarda, and et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET Eur. Heart J. 27 12 2006 1440 1446
3. S.S. Patel, M.Z. Molnar, J.A. Tayek, J.H. Ix, N. Noori, D. Benner, and et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature J. Cachex. Sarcopenia Muscle 4 1 2013 19 29
4. A. Cohen-Solal, C. Leclercq, A. Mebazaa, P. De Groote, T. Damy, R. Isnard, and et al. Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists Arch. Cardiovasc. Dis. 2014 10.1016/j.acvd.2014.07.049 (pii: S1875-2136(14)00224-1)
5. J.A. Ezekowitz, F.A. McAlister, and P.W. Armstrong Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure Circulation 107 2 2003 223 225
6. E.A. Jankowska, S. von Haehling, S.D. Anker, I.C. Macdougall, and P. Ponikowski Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives Eur. Heart J. 34 11 2013 816 829
7. N. Ebner, and S. von Haehling Iron deficiency in heart failure: a practical guide Nutrients 5 9 2013 3730 3739
8. P.A. McCullough, D. Barnard, R. Clare, S.J. Ellis, J.L. Fleg, G.C. Fonarow, and et al. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function Clin. Cardiol. 36 10 2013 611 620
9. C.M. Rhee, and K. Kalantar-Zadeh Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients? J. Cachex. Sarcopenia Muscle 5 3 2014 177 180
10. S. von Haehling, M. Lainscak, W. Doehner, P. Ponikowski, G. Rosano, J. Jordan, and et al. Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating co-morbidities Aggravating Heart Failure (SICA-HF) J. Cachex. Sarcopenia Muscle 1 2 2010 187 194
11. J.J. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. J. Heart Fail. 14 2012 803 869
12. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, and et al. Ferric carboxymaltose in patients with heart failure and iron deficiency N. Engl. J. Med. 361 25 2009 2436 2448
13. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann. Intern. Med. 130 1999 461 470
14. R.A. Bruce, J.R. Blackmon, J.W. Jones, and G. Strait Exercise testing in adult normal subjects and cardiac patients Pediatrics 32 Suppl 1963 742 756
15. S. von Haehling, and S.D. Anker Cardio-renal anemia syndrome Contrib. Nephrol. 171 2011 266 273
16. M.E. Emans Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC - Norfolk study Int. J. Cardiol. 168 4 2013 3550 3555
17. B. Young, and J. Zaritsky Hepcidin for clinicians Clin. J. Am. Soc. Nephrol. 4 2009 1384 1387
18. S. von Haehling, E.A. Jankowska, P. Ponikowski, and S.D. Anker Anemia in heart failure: an overview of current concepts Futur. Cardiol. 7 1 2011 119 129
19. P. Hatamizadeh, G.C. Fonarow, M.J. Budoff, S. Darabian, C.P. Kovesdy, and K. Kalantar-Zadeh Cardiorenal syndrome: pathophysiology and potential targets for clinical management Nat. Rev. Nephrol. 2012 10.1038/nrneph.2012.279
20. J.E. Toblli, D.S. Silverberg, F. Gennaro, P. Duarte, M. Facchini, and M. Angerosa CRAS cardio renal anaemia syndrome. Basic and clinical aspects Anaemia Working Group Latin Amerika, Publicaciones Latinoamericanas SRL 1th ed. 2008 978-987-23057-3-4 56 67 (chapter 5: iron metabolism)
21. S. von Haehling, J.C. Schefold, L.M. Hodoscek, W. Doehner, M. Mannaa, S.D. Anker, and et al. Anaemia is an independent predictor of death in patients hospitalized for acute heart failure Clin. Res. Cardiol. 99 2 2010 Feb 107 113
22. E. O'Meara, and S. de Denus Management of anemia and iron deficiency in heart failure Curr. Treat. Options Cardiovasc. Med. 12 2010 532 548
23. E.A. Jankowska, J. Malyszko, H. Ardehali, E. Koc-Zorawska, W. Banasiak, S. von Haehling, and et al. Iron status in patients with chronic heart failure Eur. Heart J. 34 11 2013 827 834
24. G. Weiss, and L.T. Goodnough Anemia of chronic disease N. Engl. J. Med. 352 2005 1011 1023
25. G.K. Nainan, V.R. Pathak, S.S. Dalal, S. Saxena, D. Mittal, T.R. Raju, and et al. A single arm, prospective, open label, multicentre study for evaluation of efficacy and safety of IV CERA for treatment of chronic renal anaemia in dialysis patients not currently treated with ESA J. Assoc. Physicians India 62 3 2014 232 236
26. A. Covic, I. Nistor, M.D. Donciu, R. Dumea, D. Bolignano, and D. Goldsmith Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: a meta-analysis of 19 studies Am. J. Nephrol. 40 3 2014 263 279
27. M. Akaishi, M. Hiroe, Y. Hada, M. Suzuki, Y. Tsubakihara, T. Akizawa, and et al. Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease J. Cardiol. 62 4 2013 249 256
28. L. Beck-da-Silva, D. Piardi, S. Soder, L.E. Rohde, A.C. Pereira-Barretto, D. de Albuquerque, and et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia Int. J. Cardiol. 168 4 2013 3439 3442
29. T. McDonagh, and I.C. Macdougall Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur. J. Heart Fail. 2015 30
30. K. Swedberg, J.B. Young, I.S. Anand, S. Cheng, A.S. Desai, R. Diaz, and et al. Treatment of anemia with darbepoetin alfa in systolic heart failure N. Engl. J. Med. 368 13 2013 1210 1219 (28)
31. H. Nasri Renal cell protection of erythropoietin beyond correcting the anemia in chronic kidney disease patients Cell J. 15 4 2014 378 380
32. S. Oba, E. Suzuki, H. Nishimatsu, S. Kumano, C. Hosoda, Y. Homma, and et al. Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway Int. J. Urol. 19 3 2012 248 255